Author

C. Uribe-Alvarez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

D. Araiza-Olivera· 2 shared J. Chernoff· 2 shared A. C. Cannon· 1 shared A. Cannon· 1 shared A. M. Kurimchak· 1 shared A. Muhlia Almazan· 1 shared E. Espinoza-Simon· 1 shared J. Rhodes· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Araiza-Olivera

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints

A. C. Cannon, K. Budagyan, C. Uribe-Alvarez, A. M. Kurimchak, D. Araiza-Olivera, K. Q. Cai, S. Peri, Y. Zhou, J. S. Duncan, J. Chernoff

This study identifies CDK9 as a novel therapeutic target in RAC1P29S-mutant melanoma and shows that combining CDK9 inhibition with anti-PD-1 therapy enhances tumor suppression.

bioRxiv · Jun 27, 2023 · PreprintCancer Biology

Targeting effector pathways in RAC1P29S-driven malignant melanoma

C. Uribe-Alvarez, S. L. Guerrero-Rodriguez, J. Rhodes, A. Cannon, J. Chernoff, D. Araiza-Olivera

This study investigates the efficacy of targeting effector pathways of RAC1P29S in melanoma, showing that PAK and SRF/MRTF inhibitors reduce tumor growth in vitro and in zebrafish models.

bioRxiv · Aug 28, 2019Cancer Biology

Staphylococcus epidermidis metabolic adaptation and biofilm formation in response to varying oxygen.

U. Pedroza-Davila, C. Uribe-Alvarez, L. Morales-Garcia, E. Espinoza-Simon, A. Muhlia Almazan, N. Chiquete-Felix, S. Uribe-Carvajal

This study examines how Staphylococcus epidermidis adapts its metabolism and forms biofilms in response to varying oxygen levels.

bioRxiv · Jun 11, 2019 · PreprintPhysiology